Healthcare and Life Science in Gdańsk
There are several dedicated centres for biomedical and life science research and linked industrial partners throughout the TriCity. The University of Gdańsk’s main biomedical activities are conducted within the highly-ranked and internationally reputed Intercollegiate Faculty of Biotechnology, a unique joint formation with the Medical University.
The range of research activities with a great emphasis on molecular biology and medical research conducted there are complemented by research groups focused on medicinal drug discovery, carried out at the Chemistry Department and the Faculty of Pharmacy at the Medical University of Gdańsk.
University of Gdańsk
The University of Gdańsk is one of the fastest growing universities in Poland, combining long-standing academic traditions with innovative way of thinking. The University capitalises on a new multi-million infrastructure and state-of-the-art facilities, located in the newly-build Oliva Campus.
Apart from the focus on the excellence in science, a part of the University’s vision is to promote dynamic collaboration with the industry and create a hub for entrepreneurs in the north of Poland.
International Centre for Cancer Vaccine Science
International Centre for Cancer Vaccine Science (ICCVS) has been established by the University of Gdańsk and with a strategic partnership of the University of Edinburgh is supported by the Foundation for Polish Science and EU (through International Research Agenda Programme; IRAP).
The research activities of the centre revolves around molecular and immunological mechanisms of cancer. The ultimate vision of the ICCVS is to propose novel innovative tactics for cancer patient therapy, especially those related to immunotherapy approaches.
“3P-Medicine – Preventive, Personalized, Precision”, is a newly-established IRAP centre for research in acquired genetic anomalies as a risk factors for diseases of aging civilization such as cancer.
Located at the Medical University of Gdańsk and with cooperation with the Uppsala University in Sweden 3P-Medicine has also received financial seed support from the Foundation for Polish Science and EU. Current focus are breast, prostate, colon and bladder cancer and Alzheimer’s disease.